Stanford Cardiovascular Institute

We are excited to share that?numerous members of the Stanford Cardiovascular Institute?will be presenting their novel and innovative research at this year’s AHA Scientific Sessions! This is an incredible opportunity to witness the latest advancements from our community, and we encourage all attendees to take a moment to see which of our members will be sharing their work, whether through presentations or posters. Don’t miss the chance to support your colleagues, learn from their cutting-edge discoveries, and make the most of this inspiring event. For more information, please visit this following link: https://lnkd.in/gJz3m54b

The Stanford Cardiovascular Institute (CVI) is always looking for exceptional postdoctoral researchers across a variety of disciplines. Use the?CVI Postdoc Application Portal?to submit your CV and a brief statement of research interests to CVI. Your application will be reviewed by Stanford faculty across a wide range of disciplines who are actively seeking to grow their labs by recruiting postdoctoral researchers. The expected base pay for these positions is the Stanford University required minimum for all postdoctoral scholars appointed through the Office of Postdoctoral Affairs. The FY24 minimum is $71,650. Apply using this link: https://lnkd.in/ghzvrNpj

We are excited to announce that registration for the west coast’s premiere drug discovery event, the?9th Annual Stanford Drug Discovery Symposium (SDDS?2025), is now open! Join us on April 28-29, 2025, at our new venue. Space is limited, so be sure to register early to secure your spot. ? SDDS?2025?presents?a chance to hear about the latest advancements from leaders in the industry, FDA, VC, academia, and others. Speakers will share their thoughts on a broad range of policy, research, and venture topics. For more information, please visit:?www.tinyurl.com/SDDS2025.?Don't miss out on this exciting event!?Below are details of our upcoming event.?

Congratulations to the 2024 Boring Trust Research Award Winners!

We are excited to share innovative research from Stanford Cardiovascular Institute members Dilip Thomas, Chikage Noishiki, MD, PhD, and senior author Nazish Sayed, MD PhD, featured in?Nature Cardiovascular Research. Their work uncovers how long COVID impacts heart health through immune response, inflammation, and endothelial cell dysfunction. Using innovative 3D organoids, this study sheds light on how COVID-19 influences the heart, leading to lasting cardiovascular issues. Read the study to learn more about potential therapeutic strategies targeting endothelial dysfunction to prevent heart failure in long COVID patients: https://lnkd.in/gFEg7hr2 Other contributors at Stanford include David Wu, Amit Manhas, Ph.D., Yu Liu, Dipti Tripathi, PhD, Ronald L. Dalman MD, Karim Sallam, Jason Lee, Joseph C. Wu, and others for their incredible work! #LongCOVID #CardiovascularHealth #Research #NatureCVR #StanfordMedicine #EndothelialDysfunction #HeartHealth #COVID19 ?

The?Computational medicine in the Heart: Integrated training Program (CHIP?T32)?for?postdoctoral?researchers is?currently?open?for applications! ? CHIP?T32?offers cutting edge training at the intersection of engineering with the life sciences to develop novel strategies to define disease mechanisms and improve therapy.?CHIP?emphasizes computational medicine: the connection between computational approaches, data science including machine learning and cardiovascular physiology and medicine. Applications are due November 1st, 2024. Apply here: https://lnkd.in/gSZqtRW2

Congratulations to our 2024 Seed Grant Award Awardees! Please check out this link to learn more about our awardees and their projects: https://lnkd.in/gmEp3pP8.

We want to recognize the profound impact of the women at CVI and Stanford Medicine who contribute their talent, skill, and innovation to their work as leaders, physicians, researchers, and educators. On behalf of the CVI community, we extend our admiration and gratitude to our colleagues for their tremendous contributions to the fields of?medicine?and biomedicine?at CVI and Stanford?Medicine.

The Stanford Cardiovascular Institute would like to invite you to participate in the?Drug Development: Key Issues in Regulation, Benefit vs Risk, and Commercialization (MED227) course happening this fall.?These are?graduate level?courses, which postdocs are welcome to audit. Please see below for more details!

We are excited to present the 7th?Annual?Gootter-Jensen Foundation Lecture in Sudden Cardiac Death tomorrow, September 17th from 12-1pm in Li Ka Shing Center, LK101/LK102.?This?event?will be?available both?in-person and via?Zoom, with the?Zoom?webinar open to the public. We encourage you to attend and have a lively Q&A discussion. Below are details of our upcoming?event or visit the following link: https://lnkd.in/gdHsfwrU.